Mitochondrial DNA and Ape1 in Huntington's Disease
亨廷顿病中的线粒体 DNA 和 Ape1
基本信息
- 批准号:9314641
- 负责人:
- 金额:$ 29.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-07-01 至 2019-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAgeAgingBase Excision RepairsBioenergeticsBiological AssayBrainCellsConfocal MicroscopyCorpus striatum structureDNA RepairDetectionDevelopmentExhibitsGenesGoalsHistologyHumanHuntington DiseaseHuntington geneInterventionKnock-in MouseLesionMaintenanceMeasuresMediatingMitochondriaMitochondrial DNAModificationMotorMusMutationNerveNerve DegenerationNeuropathogenesisOxidation-ReductionOxidative StressPathway interactionsPatientsPerformancePharmacologyPlayProductionPublicationsResearchRoleSiteSmall Interfering RNASourceStaining methodStainsSynapsesSynaptosomesTestingUnited States National Institutes of Healthage effectage relatedagedbasedisease phenotypeendonucleaseexperimental studyextracellularin vitro Modelin vivoinsightmitochondrial dysfunctionmouse modelmutantneuronal survivalnoveloxidative damagepreventpublic health relevancerepairedrespiratorytranscription factor
项目摘要
DESCRIPTION (provided by applicant): Substantial evidence suggests that oxidative stress and mitochondrial dysfunction may play a role in neurodegeneration associated with HD. However, the precise mechanism(s) by which mutant huntingtin (htt) causes mitochondrial dysfunction remain largely unknown. We recently demonstrated a regulatory role of Ape1, the major mammalian apurinic/apyrimidinic (AP) endonuclease that participates in the base excision repair (BER) pathway, on mitochondrial function. Thus, our main objective is to determine the mechanisms of Ape1-mediated mitochondrial dysfunction in the context of mutant htt. This proposal will test the hypothesis that mutant htt, in combination with age-related effects, mediates mitochondrial dysfunction and neurodegeneration by targeting Ape1, which in turn results in deficient repair of mtDNA. We propose to test our hypothesis using a combination of in vivo and in vitro models of HD and directly test our hypothesis by determining if: 1) age-related changes in Ape1 synaptic nerve terminals contribute to mtDNA damage, mitochondrial dysfunction and neurodegeneration in HD and 2) what mechanism(s) might trigger Ape1-associated mitochondrial dysfunction in the context of the htt mutation. This study is likely to provide insight into a possible regulatory mechanism of Ape1 in mutant htt-induced mt dysfunction and neurodegeneration.
描述(由适用提供):大量证据表明,氧化应激和线粒体功能障碍可能在与HD相关的神经变性中起作用。然而,突变亨廷顿蛋白(HTT)引起线粒体功能障碍的确切机制仍然未知。最近,我们证明了APE1(主要哺乳动物的肾上腺素/apyrimidinic(AP)核酸内切酶,该核酸酶参与线粒体功能。这是我们的主要目标是确定在突变htt的背景下,APE1介导的线粒体功能障碍的机理。该提案将检验以下假设:突变体HTT与年龄相关的效应结合使用,通过靶向APE1介导线粒体功能障碍和神经变性,这又导致MTDNA修复不足。 We propose to test our hypothesis using a combination of in vivo and in vitro models of HD and directly test our hypothesis by determining if: 1) age-related changes in Ape1 synaptic nerve terminals contribute to mtDNA damage, mitochondrial dysfunction and neurodegeneration in HD and 2) what mechanism(s) might trigger Ape1-associated mitochondrial dysfunction in the HTT突变的上下文。这项研究可能会深入了解突变HTT诱导的MT功能障碍和神经变性中APE1的可能调节机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sylvette Ayala-Pena其他文献
Sylvette Ayala-Pena的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sylvette Ayala-Pena', 18)}}的其他基金
APE1 and Somatic Expansion in Huntington's Disease
APE1 和亨廷顿病的体细胞扩张
- 批准号:
10557125 - 财政年份:2022
- 资助金额:
$ 29.57万 - 项目类别:
APE1 and Somatic Expansion in Huntington's Disease
APE1 和亨廷顿病的体细胞扩张
- 批准号:
10332662 - 财政年份:2022
- 资助金额:
$ 29.57万 - 项目类别:
Mitochondrial DNA and Ape1 in Huntington's Disease
亨廷顿病中的线粒体 DNA 和 Ape1
- 批准号:
8854491 - 财政年份:2015
- 资助金额:
$ 29.57万 - 项目类别:
Mitochondrial DNA and Ape1 in Huntington's Disease
亨廷顿病中的线粒体 DNA 和 Ape1
- 批准号:
9096276 - 财政年份:2015
- 资助金额:
$ 29.57万 - 项目类别:
相似国自然基金
TBX20在致盲性老化相关疾病年龄相关性黄斑变性中的作用和机制研究
- 批准号:82220108016
- 批准年份:2022
- 资助金额:252 万元
- 项目类别:国际(地区)合作与交流项目
LncRNA ALB调控LC3B活化及自噬在体外再生晶状体老化及年龄相关性白内障发病中的作用及机制研究
- 批准号:81800806
- 批准年份:2018
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
APE1调控晶状体上皮细胞老化在年龄相关性白内障发病中的作用及机制研究
- 批准号:81700824
- 批准年份:2017
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
KDM4A调控平滑肌细胞自噬在年龄相关性血管老化中的作用及机制
- 批准号:81670269
- 批准年份:2016
- 资助金额:55.0 万元
- 项目类别:面上项目
老年人一体化编码的认知神经机制探索与干预研究:一种减少与老化相关的联结记忆缺陷的新途径
- 批准号:31470998
- 批准年份:2014
- 资助金额:87.0 万元
- 项目类别:面上项目
相似海外基金
The Influence of Lifetime Occupational Experience on Cognitive Trajectories Among Mexican Older Adults
终生职业经历对墨西哥老年人认知轨迹的影响
- 批准号:
10748606 - 财政年份:2024
- 资助金额:
$ 29.57万 - 项目类别:
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 29.57万 - 项目类别:
Fluency from Flesh to Filament: Collation, Representation, and Analysis of Multi-Scale Neuroimaging data to Characterize and Diagnose Alzheimer's Disease
从肉体到细丝的流畅性:多尺度神经影像数据的整理、表示和分析,以表征和诊断阿尔茨海默病
- 批准号:
10462257 - 财政年份:2023
- 资助金额:
$ 29.57万 - 项目类别:
Understanding the Mechanisms and Consequences of Basement Membrane Aging in Vivo
了解体内基底膜老化的机制和后果
- 批准号:
10465010 - 财政年份:2023
- 资助金额:
$ 29.57万 - 项目类别:
Project 3: 3-D Molecular Atlas of cerebral amyloid angiopathy in the aging brain with and without co-pathology
项目 3:有或没有共同病理的衰老大脑中脑淀粉样血管病的 3-D 分子图谱
- 批准号:
10555899 - 财政年份:2023
- 资助金额:
$ 29.57万 - 项目类别: